NC
NGVT icon

North Capital’s Ingevity NGVT Stock Holding History

North Capital’s Portfolio NGVT Stock Details NGVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-1
Closed -$55 – 480
2025
Q3 		$55 Buy
+1
New +$52 ﹤0.01% 698

Other funds holding NGVT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $8.43B AUM 52.02% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
SCM
Simcoe Capital Management New York $549M AUM 24.95% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

North Capital's NGVT Position: Q4 2025 in Review

North Capital sold out of Ingevity (NGVT) in Q4 2025, closing a stake of 1 share — an estimated $55 sold.

North Capital first reported a position in NGVT in Q3 2025 and held it in 1 quarter. The position peaked at $55 in Q3 2025. 303 funds tracked by Wall St. Rank hold NGVT as of Q4 2025.

  • North Capital reported no remaining Ingevity position as of Q4 2025 after selling out during the quarter.
  • North Capital sold 1 Ingevity share in Q4 2025, an estimated $55.
  • North Capital first reported a position in Ingevity in Q3 2025 and held it in 1 quarter.
  • North Capital's Ingevity position peaked at $55 in Q3 2025.
  • 303 funds tracked by Wall St. Rank held Ingevity as of Q4 2025.

Based on North Capital's 13F filing for Q4 2025, filed 18 Feb 2026.